Paulus F Van Der Meij

Title: Paulus F Van Der Meij: Innovator in Pharmaceutical Chemistry

Introduction

Paulus F Van Der Meij is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing enantiomerically pure compounds. With a total of 2 patents to his name, his work has implications for the pharmaceutical industry.

Latest Patents

One of his latest patents is titled "Process for the preparation of enantiomerically pure imidazolyl compounds." This invention describes a method for creating an enantiomerically pure imidazolyl compound through a series of steps involving the use of optically active forms of pyroglutamic acid. The process includes the separation of crystallized acid addition salts and optional recrystallization to achieve the desired enantiomeric purity.

Another significant patent by Van Der Meij is focused on the "Production of dobutamine compounds." This invention outlines a process for producing an acid addition salt of a dobutamine compound by reacting a mineral acid-addition salt of a dopamine compound with a ketone, utilizing a catalytic amount of a base and hydrogenation catalyst. The careful adjustment of pH and isolation of the product are key steps in this innovative process.

Career Highlights

Paulus F Van Der Meij is associated with Duphar International Research Bv, where he continues to advance his research in pharmaceutical chemistry. His work has been instrumental in developing new methods that enhance the efficiency and effectiveness of drug production.

Collaborations

Throughout his career, Van Der Meij has collaborated with notable colleagues, including Jan-Maarten Verbeek and Paulus P De Jong. These collaborations have contributed to the advancement of research and innovation in their field.

Conclusion

Paulus F Van Der Meij is a distinguished inventor whose contributions to pharmaceutical chemistry have paved the way for advancements in drug production. His innovative patents reflect his commitment to enhancing the efficacy of pharmaceutical compounds.